Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4L3O

Crystal Structure of SIRT2 in complex with the macrocyclic peptide S2iL5

Summary for 4L3O
Entry DOI10.2210/pdb4l3o/pdb
Related PRD IDPRD_001104
DescriptorNAD-dependent protein deacetylase sirtuin-2, cyclic peptide S2iL5, ZINC ION, ... (6 entities in total)
Functional Keywordsmacrocyclic peptide, structural change, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceHomo sapiens (human)
More
Cellular locationCytoplasm, cytoskeleton: Q8IXJ6
Total number of polymer chains8
Total formula weight146345.71
Authors
Yamagata, K.,Nishimasu, H.,Ishitani, R.,Nureki, O. (deposition date: 2013-06-06, release date: 2014-02-19, Last modification date: 2023-11-08)
Primary citationYamagata, K.,Goto, Y.,Nishimasu, H.,Morimoto, J.,Ishitani, R.,Dohmae, N.,Takeda, N.,Nagai, R.,Komuro, I.,Suga, H.,Nureki, O.
Structural Basis for Potent Inhibition of SIRT2 Deacetylase by a Macrocyclic Peptide Inducing Dynamic Structural Change
Structure, 22:345-352, 2013
Cited by
PubMed Abstract: SIRT2 deacetylates specific acetyllysine residues in diverse proteins and is implicated in a variety of cellular processes. SIRT2 inhibition thus has potentials to treat human diseases such as cancers and neurodegenerative disorders. We have recently developed a series of ε-trifluoroacetyllysine-containing macrocyclic peptides, which inhibit the SIRT2 activity more potently than most other known inhibitors. Here, we report the crystal structure of human SIRT2 in complex with a macrocyclic peptide inhibitor, S2iL5, at 2.5 Å resolution. The structure revealed that S2iL5 binds to the active site of SIRT2 through extensive interactions. A structural comparison of the SIRT2-S2iL5 complex with SIRT2 in the free form, and in complex with ADP-ribose, revealed that S2iL5 induces an open-to-closed domain movement and an unexpected helix-to-coil transition in a SIRT2-specific region. Our findings unveil the potential of macrocyclic peptides to bind target proteins by inducing dynamic structural changes.
PubMed: 24389023
DOI: 10.1016/j.str.2013.12.001
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.518 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon